Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery: A National Real-World Cohort Study
- 09.02.2024
- Thoracic Oncology
Erschienen in:
- Verfasst von
- Jun-Peng Lin, PhD
- Xiao-Feng Chen, MD
- Peiyuan Wang, PhD
- Hao He, MD
- Wei-Jie Chen, MD
- Feng-Nian Zhuang, MD
- Hang Zhou, MD
- Yu-Jie Chen, MD
- Wen-Wei Wei, MD
- Shuo-Yan Liu, MD
- Feng Wang, MD
- Erschienen in
- Annals of Surgical Oncology | Ausgabe 7/2024
Abstract
Background
The prognosis of limited-stage small cell lung cancer (LS-SCLC) after surgery usually is estimated at diagnosis, but how the prognosis actually evolves over time for patients who survived for a predefined time is unknown.
Methods
Data on patients with a diagnosis of LS-SCLC after surgery between 2004 and 2015 were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. The 5-year conditional cancer-specific survival (CCSS) and conditional overall survival (COS) were calculated.
Results
This study analyzed 997 patients (555 women, 55.7%) with a median age, of 67 years (interquartile range [IQR], 60–73 years). The 5-year CCSS and COS increased from 44.7% and 38.3%, respectively, at diagnosis to 83.7% and 67.9% at 5 years after diagnosis. Although there were large differences with different stages (stages I, II, and III) at diagnosis (respectively 59.5%, 28.4%; 28.1% for CCSS and 50.6%, 24.8%, and 23.6% for COS), the gap decreased with time, and the rates were similar after 5 years (respectively 85.0%, 80.3%, and 79.4% for CCSS; 65.6%, 56.9%, and 61.3% for COS). The 5-year conditional survival for the patients who received lobectomy was better than for those who received sublobectomy or pneumonectomy. Multivariable analyses showed that only age and resection type were independent predictors for CCSS and COS, respectively, throughout the period.
Conclusion
Conditional survival estimates for LS-SCLC generally increased over time, with the most significant improvement in patients with advanced stage of disease. Resection type and old age represented extremely important determinants of prognosis after a lengthy event-free follow-up period.
Anzeige
- Titel
- Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery: A National Real-World Cohort Study
- Verfasst von
-
Jun-Peng Lin, PhD
Xiao-Feng Chen, MD
Peiyuan Wang, PhD
Hao He, MD
Wei-Jie Chen, MD
Feng-Nian Zhuang, MD
Hang Zhou, MD
Yu-Jie Chen, MD
Wen-Wei Wei, MD
Shuo-Yan Liu, MD
Feng Wang, MD
- Publikationsdatum
- 09.02.2024
- Verlag
- Springer International Publishing
- Erschienen in
-
Annals of Surgical Oncology / Ausgabe 7/2024
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681 - DOI
- https://doi.org/10.1245/s10434-024-14983-w
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
